This inventor holds 6 USPTO granted patents and 2 EPO patents. Top assignees: Ambit Biosciences Corporation, Neurocrine Biosciences, Inc.. Active years: 2002-2017.
Company Filing History:
Years Active: 2002-2017
Title: Patrick B O'Donnell: Innovator in Proliferative Disease Treatments
Introduction
Patrick B O'Donnell is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medicine, particularly in the treatment of proliferative diseases. With a total of 6 patents to his name, O'Donnell's work has the potential to impact many lives.
Latest Patents
O'Donnell's latest patents focus on innovative methods for treating proliferative diseases. One of his key inventions involves the administration of N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, or its pharmaceutically acceptable salts or solvates. These methods include specific dosing schedules and regimens tailored for human patients, particularly those with FLT-3 mediated diseases.
Career Highlights
Throughout his career, Patrick B O'Donnell has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Neurocrine Biosciences, Inc. and Ambit Biosciences Corporation. His work in these organizations has allowed him to develop and refine his innovative approaches to treating complex diseases.
Collaborations
O'Donnell has collaborated with several esteemed professionals in his field, including William Jay Thiele and Joyce K James. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Patrick B O'Donnell stands out as a significant figure in the realm of medical innovation. His dedication to developing effective treatments for proliferative diseases showcases his commitment to improving patient outcomes. His contributions will likely continue to influence the field for years to come.